Program Information
Dosimetric Characterization of a New HDR Multi-Channel Esophageal Applicator for Brachytherapy
A Zhao1*, T Diener2 , S Gao1 , J Greskovich1 , D Wilkinson1 , (1) Cleveland Clinic, Cleveland, OH, (2) Cleveland State University, Cleveland, OH
Presentations
SU-G-TeP2-7 (Sunday, July 31, 2016) 4:30 PM - 5:00 PM Room: ePoster Theater
Purpose: To characterize the dose distribution of a new multi-channel esophageal applicator for brachytherapy HDR treatment, and particularly the effect of the presence of air or water in the applicator’s expansion balloon.
Methods: A new multi-channel (6) inflatable applicator for esophageal HDR has been developed in house and tested in a simple water phantom. CT image sets were obtained under several balloon expansions (80ml of air, 50 cc of water), and channel loadings and used with the Oncentra (Elekta) planning system based on TG43 formalism. 400 cGy was prescribed to a plane 1cm away from the applicator. Planar dose distributions were measured for that plane and one next to the applicator using Gafchromic EBT3 film and scanned by a Vidar VXR-12 film digitizer. Film and TPS generated dose distributions of film were sent to OmniPro I’mRT (iba DOSIMETRY) for analysis. 2D dose profiles in both X and Y directions were compared and gamma analysis performed.
Results: Film dose measurement of the air-inflated applicator is lower than the TPS calculated dose by as much as 60%. Only 80.8% of the pixels passed the gamma criteria (3%/3mm). For the water-inflated applicator, the measured film dose is fairly close to the TPS calculated dose (typically within <3%). 99.84% of the pixels passed the gamma criteria (3%/3mm).
Conclusion: TG43 based calculations worked well when water was used in the expansion balloon. However, when air is present in that balloon, the neglect of heterogeneity corrections in the TG43 calculation results in large differences between calculated and measured doses. This could result in severe underdosing when used in a patient. This study illustrates the need for a TPS with an advanced algorithm which can account for heterogeneity.
Funding Support, Disclosures, and Conflict of Interest: Supported by Innovations Department, Cleveland Clinic.
Contact Email: